Omnicell, Inc.OMCL
What Omnicell, Inc. does.
Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem. Our comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management alongside 5 other outcomes laid out in the Autonomous Pharmacy framework.
In 2024, the United States spent $806 billion on prescription drugs, a 10.2% increase from 2023. We believe there are significant challenges facing the practice of pharmacy today. These challenges include, but are not limited to, budget constraints and acute workforce shortages, where 88% of hospitals report technician deficits and 92% lack sufficient sterile compounding expertise. In addition, health systems face rising liability related to drug diversion, with a 61% increase in the average number of investigations per hospital since the beginning of 2023. We also recognize that these challenges may impact the timing of contracting for, or implementation of, our products, solutions, or services. However, we believe that over time these significant challenges facing pharmacists will drive demand for increased automation, visibility, insights, and improved medication management outcomes that our solutions are designed to enable. Because of this, we believe that our solutions are well-positioned to address the evolving needs of healthcare institutions and therefore present opportunities for long-term growth.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $892.2M | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B |
| Net income | $32.2M | $77.8M | $5.6M | -$20.4M | $12.5M | $2.1M |
| Free cash flow | $163.0M | $202.8M | $30.2M | $139.6M | $151.3M | $86.9M |
More on OMCL.
- Omnicell, Inc. summary
- Omnicell, Inc. financial statements
- Omnicell, Inc. key metrics
- Omnicell, Inc. health scores and style box
- Omnicell, Inc. earnings
- Omnicell, Inc. dividends
- Omnicell, Inc. valuation
- Omnicell, Inc. ownership and insiders
- Omnicell, Inc. peers
Figures from Omnicell, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.